1230107

Alvogen, Inc — FEI 3008454186

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 21, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Morristown, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)